<DOC>
	<DOCNO>NCT00248404</DOCNO>
	<brief_summary>The purpose trial ass tolerability safety NB1011 treatment patient cancer overexpress TS , ovarian , gastrointestinal , colorectal , bladder , breast , lung cancer .</brief_summary>
	<brief_title>NB1011 Administered Continuous Infusion Cancers That Overexpress Thymidylate Synthase ( TS )</brief_title>
	<detailed_description />
	<criteria>Advanced , recurrent , metastatic solid tumor TS overexpression ( &gt; 4 reverse transcription polymerase chain reaction [ RTPCR ] ) archival fresh sample Suitable experimental monotherapy Measurable disease Tumors biopsied low level TS expression Requirement concomitant anticancer therapy Treatment another investigational product within 30 day study entry Pregnant lactate woman Active uncontrolled serious bacterial , viral , fungal , parasitic infection . HIV infection Clinically apparent meningeal central nervous system ( CNS ) metastases carcinomatous meningitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>ovarian cancer</keyword>
	<keyword>lung cancer</keyword>
	<keyword>breast cancer</keyword>
	<keyword>small bowel cancer</keyword>
	<keyword>Advanced , recurrent , metastatic solid tumor type</keyword>
	<keyword>TS overexpression confirm fresh biopsy ( RTPCR )</keyword>
	<keyword>Suitable experimental monotherapy</keyword>
</DOC>